Results 51 to 60 of about 485 (159)

Issue Information

open access: yesiLABMED, Volume 4, Issue 3, Page i-v, September 2026.
No abstract is available for this article.
wiley   +2 more sources

Menopausal insomnia as a modifiable node of dementia risk: Mechanistic insights and intervention strategies

open access: yesAlzheimer's &Dementia, Volume 22, Issue 8, August 2026.
Abstract The menopausal transition is often accompanied by neuropsychiatric symptoms such as sleep disturbances, representing a modifiable window for Alzheimer's disease and related dementia (ADRD) prevention. Current preventive strategies fail to address the heterogeneity of postmenopausal cognitive trajectories, where some women exhibit rapid ...
Wenjing Zhang   +9 more
wiley   +1 more source

Migraine and Its Treatment from the Medicinal Chemistry Perspective [PDF]

open access: yes
Migraine is a disease of neurovascular origin that affects the quality of life of more than one billion people and ranks sixth among the most common diseases in the world. Migraine is characterized by a moderate or severe recurrent and throbbing headache,
Carradori S., Pehlivanlar E., Simsek R.
core   +2 more sources

Individual Narrative and Literary Transgression in Me and Ditan

open access: yesJournal of Education and Educational Research
Current scholarship on Shi Tiesheng’s Me and Ditan has largely focused on the intrinsic characteristics of the text itself. Relatively few studies approach the work through the author’s notion that “literature is transgression,” nor do they integrate individual narrative with the progressive process of “transgression” embedded in literary expression to
openaire   +1 more source

An Explainable Machine Learning Model for Early Prediction of Incident Myocardial Injury in Patients With Severe Fever With Thrombocytopenia Syndrome

open access: yesJournal of Medical Virology, Volume 98, Issue 7, July 2026.
ABSTRACT This study aimed to develop an explainable machine learning–based model to enable early prediction of incident myocardial injury during hospitalization among patients with severe fever with thrombocytopenia syndrome (SFTS). This multicenter retrospective cohort study included and analyzed clinical data from 1,088 patients with SFTS who were ...
Xiang Li   +11 more
wiley   +1 more source

The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 7, Page 1628-1643, July/August 2026.
Abstract Background Calcitonin gene‐related peptide (CGRP) is a key mediator in migraine pathophysiology, and the development of gepants, novel CGRP receptor antagonists, has expanded therapeutic options for both acute and preventive treatment. This scoping review aims to synthesize current evidence on the pharmacology, clinical applications, safety ...
Luigi Francesco Iannone   +5 more
wiley   +1 more source

Acute pharmacological treatments for migraine: A systematic review with Mexican healthcare perspective

open access: yesCephalalgia Reports
Introduction Migraine is a common and disabling neurological disorder that requires effective acute treatment. However, access to optimal therapies varies significantly across healthcare systems worldwide.
Maria-Karina Velez-Jimenez   +12 more
doaj   +1 more source

Nanjing Consensus II on Washed Microbiota Transplantation: Statements From the CHINAGUT Conference

open access: yesMicrobiota Medicine Research, Volume 1, Issue 2, Page 45-62, June 2026.
ABSTRACT The new method of fecal microbiota transplantation, based on automatic facilities and washing processes, was coined as washed microbiota transplantation (WMT). The first recommendations on WMT were released as Nanjing Consensus report by the fecal microbiota transplantation (FMT)‐standardization Study Group in 2019.
Faming Zhang   +53 more
wiley   +1 more source

MIGRAINE TREATMENT BEYOND TRADITIONAL THERAPIES: CURRENT TRENDS AND FUTURE DIRECTIONS

open access: yes
Migraine is a highly prevalent neurological disease associated with considerable personal, social, and economic burden. The disease represents a major contributor to disability and reduced quality of life.
Katarzyna Bednarczuk   +19 more
core   +1 more source

Pharmacologic MRI Brain Imaging Studies of Serotonin 5‐HT1 Receptor Agonists in Awake Mice

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Serotonin (5‐hydroxytryptamine, 5‐HT) type‐1 G protein‐coupled receptors are expressed throughout the central nervous system. 5‐HT1AR activation is the putative mechanism of approved drugs for generalized anxiety disorder and major depressive disorder and is being studied in the treatment of autism and neurological disorders.
Brittany M. Brems   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy